Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Sanghee Hong"'
Autor:
Santiago Mercadal, Kwang Woo Ahn, Mariam Allbee-Johnson, Siddhartha Ganguly, Praveen Ramakrishnan Geethakumari, Sanghee Hong, Adriana Malone, Hemant Murthy, Attaphol Pawarode, Alejandro R. Sica, Melhem Solh, Celalettin Ustun, Mazyar Shadman, Craig S. Sauter, Mehdi Hamadani, Alex F. Herrera, Catherine J. Lee
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/0f51ee9132d14a23b24194148fb6258b
Autor:
Simona Pagliuca, Carmelo Gurnari, Colin Hercus, Sébastien Hergalant, Sanghee Hong, Adele Dhuyser, Maud D’Aveni, Alice Aarnink, Marie Thérèse Rubio, Pierre Feugier, Francesca Ferraro, Hetty E. Carraway, Ronald Sobecks, Betty K. Hamilton, Navneet S. Majhail, Valeria Visconte, Jaroslaw P. Maciejewski
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-12 (2023)
Abstract Graft-versus-leukemia (GvL) reactions are responsible for the effectiveness of allogeneic hematopoietic cell transplantation as a treatment modality for myeloid neoplasia, whereby donor T- effector cells recognize leukemia neoantigens. Howev
Externí odkaz:
https://doaj.org/article/8c1bcd077dcf4d8795e32c0ba12bd5cc
Autor:
Simona Pagliuca, Carmelo Gurnari, Sanghee Hong, Ran Zhao, Sunisa Kongkiatkamon, Laila Terkawi, Misam Zawit, Yihong Guan, Hassan Awada, Ashwin Kishtagari, Cassandra M. Kerr, Thomas LaFramboise, Bhumika J. Patel, Babal K. Jha, Hetty E. Carraway, Valeria Visconte, Navneet S. Majhail, Betty K. Hamilton, Jaroslaw P. Maciejewski
Publikováno v:
JCI Insight, Vol 6, Iss 13 (2021)
TCR repertoire diversification constitutes a foundation for successful immune reconstitution after allogeneic hematopoietic cell transplantation (allo-HCT). Deep TCR Vβ sequencing of 135 serial specimens from a cohort of 35 allo-HCT recipients/donor
Externí odkaz:
https://doaj.org/article/720a398ed82f4d6bab113a63c1654381
Autor:
Andrew C. Harris, Jaap J. Boelens, Kwang Woo Ahn, Mingwei Fei, Allistair Abraham, Andrew Artz, Christopher Dvorak, Haydar Frangoul, Cesar Freytes, Robert Peter Gale, Sanghee Hong, Hillard M. Lazarus, Alison Loren, Shin Mineishi, Taiga Nishihori, Tracey O'Brien, Kirsten Williams, Marcelo C. Pasquini, John E. Levine
Publikováno v:
Blood Advances, Vol 2, Iss 11, Pp 1198-1206 (2018)
Abstract: Busulfan combined with cyclophosphamide (BuCy) has long been considered a standard myeloablative conditioning regimen for allogeneic hematopoietic cell transplantation (HCT), including both nonmalignant conditions and myeloid diseases. Subs
Externí odkaz:
https://doaj.org/article/12f80ce0df034f8984ba03d2704a64a1
Autor:
Sanghee Hong, Lisa Rybicki, Carmelo Gurnari, Simona Pagliuca, Aiwen Zhang, Dawn Thomas, Valeria Visconte, Jibran Durrani, Ronald M. Sobecks, Matt Kalaycio, Aaron T. Gerds, Hetty E. Carraway, Sudipto Mukherjee, Mikkael A. Sekeres, Anjali S. Advani, Navneet S. Majhail, Betty K. Hamilton, Bhumika J. Patel, Jaroslaw P. Maciejewski
Publikováno v:
Bone Marrow Transplantation. 57:1615-1619
Autor:
Najla El Jurdi, Michael J. Martens, Claudio G. Brunstein, Paul O'Donnell, Stephanie J. Lee, Anita D'Souza, Brent Logan, Sanghee Hong, Anurag K. Singh, Karamjeet Sandhu, Roman M. Shapiro, Mary M. Horowitz, Betty K. Hamilton
Publikováno v:
Transplantation and Cellular Therapy.
Autor:
Sagar S. Patel, Sanghee Hong, Lisa Rybicki, Stephanie Farlow, Jane Dabney, Matt Kalaycio, Ronald Sobecks, Navneet S. Majhail, Betty K. Hamilton
Publikováno v:
Transplantation and Cellular Therapy.
Autor:
Ronald Sobecks, Deepa Jagadeesh, Faiz Anwer, Lisa Rybicki, Navneet S. Majhail, Brad Pohlman, Aaron T. Gerds, Sanghee Hong, Betty K. Hamilton, Matt Kalaycio, Donna Corrigan, Brian T. Hill, Robert M. Dean
Publikováno v:
Hematology/Oncology and Stem Cell Therapy, Vol 14, Iss 4, Pp 318-326 (2021)
Objective/Background: Relapse is the most common cause of treatment failure after allogeneic hematopoietic cell transplantation (alloHCT). No standard of care exists, and a wide range of treatments are used for post-alloHCT relapse. In the recent era
Autor:
Sanghee Hong, Navneet S. Majhail
Publikováno v:
Blood and Marrow Transplantation Long Term Management. :349-354
Autor:
Sanghee Hong, Jing Zhao, Shu Wang, Han Wang, Ji-Hyun Lee, Nosha Farhadfar, Joseph P. McGuirk, Bipin N. Savani, Hashmi K. Shahrukh, Patrick Stiff, Nandita Khera, Theresa Hahn, Alison W. Loren, Samantha M. Jaglowski, William A. Wood, Wael Saber, Jan Cerny, Shernan G. Holtan, Jana M. Reynolds, Abhinav Deol, Heather Jim, Joseph Uberti, Victoria Whalen, Jean C. Yi, Jaime Preussler, K. Scott Baker, Bronwen E. Shaw, Steven Devine, Karen Syrjala, Navneet S. Majhail, John R. Wingard, Zeina Al-Mansour
Publikováno v:
Transplant Cell Ther
The use of hematopoietic cell transplantation (HCT) has been increasing in older patients. However, the levels if distress, psychosocial functioning, and health-related quality of life (HRQOL) among older HCT survivors remains largely unknown. In thi